Comparison of <sup>18</sup>F-GE-180 and dynamic <sup>18</sup>F-FET PET in high grade glioma: a double-tracer pilot study.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 30244386.
- Also identified by DOI 10.1007/s00259-018-4166-1.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
PET represents a valuable tool for glioma imaging. In addition to amino acid tracers such as <sup>18</sup>F-FET, PET targeting the 18-kDa mitochondrial translocator-protein (TSPO) is of high interest for high-grade glioma (HGG) imaging due to its upregulation in HGG cells. <sup>18</sup>F-GE-180, a novel TSPO ligand, has shown a high target-to-background contrast in HGG. Therefore, we intra-individually compared its uptake characteristics to dynamic <sup>18</sup>F-FET PET and contrast-enhanced MRI in patients with HGG. Twenty HGG patients (nine IDH-wildtype, 11 IDH-mutant) at initial diagnosis (n = 8) or recurrence (n = 12) were consecutively included and underwent <sup>18</sup>F-GE-180 PET, dynamic <sup>18</sup>F-FET PET, and MRI. The maximal tumour-to-background ratios (TBR<sub>max</sub>) and biological tumour volumes (BTV) were evaluated in <sup>18</sup>F-GE-180 and <sup>18</sup>F-FET PET. Dynamic <sup>18</sup>F-FET PET analysis included the evaluation of minimal time-to-peak (TTP<sub>min</sub>). In MRI, the volume of contrast-enhancement was delineated (VOL<sub>CE</sub>). Volumes were spatially correlated using the Sørensen-Dice coefficient. The median TBR<sub>max</sub> tended to be higher in <sup>18</sup>F-GE-180 PET compared to <sup>18</sup>F-FET PET [4.58 (2.33-8.95) vs 3.89 (1.56-7.15); p = 0.062] in the overall group. In subgroup analyses, IDH-wildtype gliomas showed a significantly higher median TBR<sub>max</sub> in <sup>18</sup>F-GE-180 PET compared to <sup>18</sup>F-FET PET [5.45 (2.56-8.95) vs 4.06 (1.56-4.48); p = 0.008]; by contrast, no significant difference was observed in IDH-mutant gliomas [3.97 (2.33-6.81) vs 3.79 (2.01-7.15) p = 1.000]. Only 5/20 cases showed higher TBR<sub>max</sub> in <sup>18</sup>F-FET PET compared to <sup>18</sup>F-GE-180 PET, all of them being IDH-mutant gliomas. No parameter in <sup>18</sup>F-GE-180 PET correlated with TTP<sub>min</sub> (p > 0.05 each). There was a tendency towards higher median BTV<sub>GE-180</sub> [32.1 (0.4-236.0) ml] compared to BTV<sub>FET</sub> [19.3 (0.7-150.2) ml; p = 0.062] with a moderate spatial overlap [median Sørensen-Dice coefficient 0.55 (0.07-0.85)]. In MRI, median VOL<sub>CE</sub> [9.7 (0.1-72.5) ml] was significantly smaller than both BTV<sub>FET</sub> and BTV<sub>GE180</sub> (p < 0.001 each), leading to a poor spatial correlation with BTV<sub>GE-180</sub> [0.29 (0.01-0.48)] and BTV<sub>FET</sub> [0.38 (0.01-0.68)]. PET with <sup>18</sup>F-GE-180 and <sup>18</sup>F-FET provides differing imaging information in HGG dependent on the IDH-mutational status, with diverging spatial overlap and vast exceedance of contrast-enhancement in MRI. Combined PET imaging might reveal new insights regarding non-invasive characterization of tumour heterogeneity and might influence patients' management.
Medical subject headings
- Carbazoles
- Glioma
- Positron-Emission Tomography
- Tyrosine